2021-09-27
Raytor Instruments Completed the First Round of Strategic Financing
In September 2021, Raytor Instruments completed the first round of strategic financing, and the investor was Jiangsu Woutu Fund.
This round of financing of Raytor Instruments aims to deepen R&D and innovation, enhance the scale and rapid response ability of professional service team, and create an innovative and intelligent domestic instrument brand.
Woutu Fund fully trusts the innovation ability of Raytor Instruments in the dissolution field, and hopes to build stronger R&D, manufacturing and service capabilities with Raytor Instruments, provide first-class products and solutions for excellent enterprises in the pharmaceutical industry, and boost the development and upgrading of the industry.
Raytor Instruments
As a national high-tech enterprise and ISO9001 certified enterprise, Raytor Instruments has been committed to the R&D, production, sales and service of drug dissolution instruments and solutions, and provides users with overall dissolution solutions.
Raytor's products include: Pharmacopoeia full series automatic sampling and dissolution system (USP 1~7), dissolution medium preparation system, automatic sampling transdermal diffusion system, etc., which fully covers various dissolution and release test devices in Pharmacopoeia.
Woutu Fund
Woutu Fund is a venture capital equity fund with the purpose of "creating sustainable value with strategic partners". Woutu Fund has invested in the fields of acoustics, sensors, control, detection, instruments, intelligent equipment and new materials, and helped enterprises become innovative leading enterprises in the industry.
More
